Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -157,924 | -121,591 | -91,047 | -49,484 | -161,381 |
| Depreciation Amortization | 2,355 | 1,687 | 1,029 | 312 | 2,405 |
| Income taxes - deferred | 11 | N/A | N/A | 10 | 4,361 |
| Accounts receivable | -3,910 | -3,224 | -2,551 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,366 | 1,116 | 3,654 | 72 | -4,969 |
| Other Working Capital | 689 | -9,064 | -3,526 | 911 | -4,315 |
| Other Operating Activity | 31,115 | 23,662 | 13,536 | 8,057 | 27,367 |
| Operating Cash Flow | $-126,298 | $-107,414 | $-78,905 | $-40,122 | $-136,532 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 149,050 | 198,840 | 150,940 | 64,888 | -23,161 |
| PPE Investments | -415 | -164 | -113 | -54 | -283 |
| Purchase Sale Intangibles | -20,000 | -20,000 | -20,000 | -20,000 | N/A |
| Other Investing Activity | -20,000 | -20,000 | -20,000 | -20,000 | 0 |
| Investing Cash Flow | $128,635 | $178,676 | $130,827 | $44,834 | $-23,444 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,885 | 4,673 | 1,993 | 1,106 | 228,222 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,136 |
| Financing Cash Flow | $5,885 | $4,673 | $1,993 | $1,106 | $227,086 |
| Beginning Cash Position | 114,248 | 114,248 | 114,248 | 114,248 | 47,138 |
| End Cash Position | 122,470 | 190,183 | 168,163 | 120,066 | 114,248 |
| Net Cash Flow | $8,222 | $75,935 | $53,915 | $5,818 | $67,110 |
| Free Cash Flow | |||||
| Operating Cash Flow | -126,298 | -107,414 | -78,905 | -40,122 | -136,532 |
| Capital Expenditure | -415 | -164 | -113 | -54 | -283 |
| Free Cash Flow | -126,713 | -107,578 | -79,018 | -40,176 | -136,815 |